Vaping has revealed effective where official therapies failed. What is the secret of its success? A study by researchers Di Piazza, Caponnetto, Askin, Christos, Maglia, Gautam, Roche and Polosa tries to explain the reasons behind its success. The results are on the prestigious international Harm Reduction Journal.
Reflecting on the 15th Year of the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC), two international expert panel sessions featuring leading academics, researchers and NGO principals will cover the key questions and challenges facing policymakers in achieving more effective and equitable implementation globally
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
The first Tobacco Transformation Index, released today and made possible with funding from the Foundation for a Smoke-Free World, finds that most of the 15 largest tobacco companies are not making substantive progress in phasing out cigarettes and other high-risk tobacco products and transitioning smokers to reduced-risk alternatives
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
QUIT STRONG is one of the first public health initiatives in the World that embrace THR (Tobacco Harm Reduction), showing openness to strategies that can support smokers during smoking cessation programmes. Low risk products allow to provide the necessary amount of nicotine while maintaining the behavioral and psychological rituals associated to smoking
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
The findings from a survey conducted by COEHAR researchers on almost 2000 participants showed a slight decrease in the consumption of cigarettes during the lockdown period and an increase in the purchase of products such as cigarettes and e-liquid
A recent study by Prof. Brake SJ studied the correlation between smoking and the angiotensin converting enzyme 2 and its implications to COVID-19. The author's hypothesis suggests an increased risk…
We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.